Novartis warns doctors on off-label Femara use
30th Nov 2005, 17:29 GMT
ZURICH (Reuters) - Novartis has warned doctors not to use its hormone-based breast cancer drug Femara to help women become pregnant after reports of adverse events following such off-label use.
Novartis warns doctors on off-label Femara use related news:
- Breast Cancer Drug Femara May Cause Birth Defects — FOXNews.com - Health
- Health Canada, Novartis Issue Alert Against Off-Label Use of Breast Cancer Drug To Treat Infertility — Medical News Today RSS/XML Feed
- Canadian Regulators Warn Against Use of Femara as Fertility Drug — MedPage Today Endocrinology
- Novartis Warns Doctors of Misusing Cancer Drug — RedOrbit News - Health
- Novartis Warns About Breast Cancer Drug Use — NYNewsday.com Health and Science headlines
- Breast Cancer Drug Not for Fertility — WebMD Health Headlines
- Cancer Drug No Fertility Treatment — Health News: CBSnews.com
- Warning issued for breast cancer drug — MSNBC.com: Health
- DCGI may scrap Novartis' Certican clinical trials — rediff Business
- Novartis issues breast cancer drug warning. — Environmental Health News
Latest news from Reuters: Health:
- Roche flu drug to carry new caution in U.S.
- Gene chip test identifies bird flu strains
- Bristol arthritis drug effective in children: study
- World's poor still deprived of drugs: activists
- Study questions radiation after prostate removal
- Chocolate addiction leads to sweet discovery
- Researchers spur growth of adult brain stem cells
- Angioplasty no help for heart attack victims who wait
- Diabetics fare better with drug-eluting stents
- Very obese fare worse after colon cancer diagnosis